Sphinganine (d18:0)
(Synonyms: D-赤式-C18-二氢-D-神经鞘氨醇) 目录号 : GC40794Sphinganine (d18:0)是一种鞘脂代谢途径的中间体。
Cas No.:764-22-7
Sample solution is provided at 25 µL, 10mM.
Sphinganine (d18:0) is an intermediate in the sphingolipid metabolic pathway[1]. Sphinganine (d18:0) is a precursor of ceramide and sphingosine and a substrate for sphingosine kinase, which produces sphingosine-1-phosphate[2]. Sphinganine (d18:0) can be used as a standard for the quantification of epidermal ceramide by liquid chromatography-tandem mass spectrometry[3]. Sphinganine (d18:0) can be used to prepare bovine serum albumin lipid complexes to study their effects on the inhibition of non-lysosomal glucosylceramidase β2 (GBA2)[4]. Sphinganine levels are significantly increased in response to certain mycotoxins, including fumonisins, and in certain cancers[5]. Sphinganine can block the activation of protein kinase C[6].
References:
[1]Wigger D, Gulbins E, Kleuser B, et al. Monitoring the sphingolipid de novo synthesis by stable-isotope labeling and liquid chromatography-mass spectrometry[J]. Frontiers in Cell and Developmental Biology, 2019, 7: 210.
[2]Zheng W, Kollmeyer J, Symolon H, et al. Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy[J]. Biochimica et Biophysica Acta (BBA)-Biomembranes, 2006, 1758(12): 1864-1884.
[3]Wang Z, Kirkwood J S, Taylor A W, et al. Transcription factor Ctip2 controls epidermal lipid metabolism and regulates expression of genes involved in sphingolipid biosynthesis during skin development[J]. Journal of Investigative Dermatology, 2013, 133(3): 668-676.
[4]Schonauer S, Körschen H G, Penno A, et al. Identification of a feedback loop involving β-glucosidase 2 and its product sphingosine sheds light on the molecular mechanisms in Gaucher disease[J]. Journal of Biological Chemistry, 2017, 292(15): 6177-6189.
[5]Shephard G S, Van Der Westhuizen L, Sewram V. Biomarkers of exposure to fumonisin mycotoxins: a review[J]. Food additives and contaminants, 2007, 24(10): 1196-1201.
[6]Smith E R, Merrill Jr A H, Obeid L M, et al. Effects of sphingosine and other sphingolipids on protein kinase C[M]//Methods in enzymology. Academic Press, 2000, 312: 361-373.
Sphinganine (d18:0)是一种鞘脂代谢途径的中间体[1]。Sphinganine (d18:0)是神经酰胺和鞘氨醇的前体,也是鞘氨醇激酶的底物,可产生鞘氨醇-1-磷酸盐[2]。Sphinganine (d18:0)能够作为液相色谱串联质谱法的标准品,用于表皮神经酰胺的定量[3]。Sphinganine (d18:0)能够用于制备牛血清白蛋白脂质复合物,研究其对非溶酶体-葡糖神经酰胺酶β2(GBA2)抑制的影响[4]。Sphinganine水平在对某些霉菌毒素(包括伏马菌素)以及某些癌症的反应中显著增加[5]。Sphinganine能够阻断蛋白激酶C的激活[6]。
Cas No. | 764-22-7 | SDF | |
别名 | D-赤式-C18-二氢-D-神经鞘氨醇 | ||
Canonical SMILES | OC[C@H](N)[C@H](O)CCCCCCCCCCCCCCC | ||
分子式 | C18H39NO2 | 分子量 | 301.5 |
溶解度 | DMSO:3mg/ml | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
1 mM | 3.3167 mL | 16.5837 mL | 33.1675 mL |
5 mM | 0.6633 mL | 3.3167 mL | 6.6335 mL |
10 mM | 0.3317 mL | 1.6584 mL | 3.3167 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet